Jinyu Bio-Technology Co Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jinyu Bio-Technology Co Ltd with three other
companies in this sector in China:
Hualan Biological Engineering Inc
sales of 1.93 billion Chinese Renmimbi [US$292.31 million]
of which 94%
was Blood Product),
Beijing SL Pharmaceutical Co Ltd
(1.01 billion Chinese Renmimbi [US$152.62 million]
of which 98%
was Pharmaceuticals Industry), and
Staidson (Beijing) Biopharmaceuticals Co Ltd
(1.40 billion Chinese Renmimbi [US$212.08 million]
of which 100%
was Pharmaceutical manufacturing).
During the year ended December of 2016, sales at
Jinyu Bio-Technology Co Ltd were 1.52 billion Chinese Renmimbi (US$229.27 million).
increase of 21.8%
versus 2015, when the company's sales were 1.25 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at Jinyu Bio-Technology Co Ltd.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
1,842.6% in 2016, from
1.96 million Chinese Renmimbi to 38.00 million Chinese Renmimbi.